The U.S. allows drugmakers to extend their patent terms to prevent cheaper generic drugs from entering the market sooner. That's bad for patients. Several countries will soon get generic versions of ...

The Trump administration has expanded TrumpRx to include more than 600 generic medications — a significant scale-up from the platform’s original focus on branded drugs under most-favored-nation ...

Jury finds Takeda liable to drug purchasers and insurers Case marks first jury verdict against drugmaker in reverse payment antitrust class action 2014 patent settlement with Par delayed generic ...

WASHINGTON, May 18 (Reuters) - U.S. President Donald Trump said on Monday that TrumpRx.gov, a government-backed website that lists discounted prescription drugs, will begin featuring generic medicines ...

President Trump on Monday announced a dramatic expansion of TrumpRx, adding more than 600 generic medications to its direct-to-consumer prescription website. The event was attended by billionaire Mark ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. When immigration agents pulled U.S. citizen Leonardo Garcia ...

Americans are unlikely to see generic versions of semaglutide — the active ingredient in Novo Nordisk’s Ozempic and Wegovy — until at least the end of 2031, according to a May 13 NBC News report. Novo ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

This is Part 2 in a series of columns about the viability of the American university system. Last week, I asked whether, as a forty-six-year-old father of two, I should keep contributing to my ...

Managing a team and enacting plans that truly push the needle at your business isn’t always an exact science. It requires equal parts experience, smart strategy, inspiration, and luck. But even when ...

Graham Brink is the Viewpoints Editor for the Tampa Bay Times. Reach him at gbrink@tampabay.com. Anyone can view a sampling of recent comments, but you must be a Times subscriber to contribute. Log in ...

Mortgage lenders are rushing to adopt AI, but many are repeating a familiar mistake: using new technology to accelerate old processes. Faster paper-pushing isn’t transformation. AI presents an ...